
Empowering Research at Victoria House
with ZEISS and the Pioneer GroupWelcome to the Innovation Suite at Victoria House, where cutting-edge research meets world-class technology. Through a strategic partnership between ZEISS, a global leader in optical and optoelectronic technology, and Pioneer Group, we are thrilled to offer tenant researchers unparalleled access to advanced imaging solutions. Located in the heart of London, Victoria House is a hub for collaboration among life sciences businesses, technology entrepreneurs, academia, and large pharma teams.
Our partnership is designed to empower researchers with state-of-the-art microscopy tools, fostering a collaborative ecosystem that accelerates breakthroughs in drug discovery, cell biology, and biomedical research.

Victoria House Bloomsbury London
Empowering Research Through Partnership
What the ZEISS partnership means for you — gain priority access to advanced imaging systems, expert guidance, and a platform to push the boundaries of your research.
- Access to Advanced Imaging Technology: ZEISS provides tenant researchers with the Celldiscoverer 7 with LSM900, a high-performance confocal microscope, and the Axiovert 5 digital imaging system, both equipped with AI-driven tools to enhance research capabilities.
- Collaborative Ecosystem: Victoria House facilitates collaboration among startups, research groups, and industry experts, enabling tenants to leverage ZEISS expertise and technology for groundbreaking innovations.
- Comprehensive Support and Training: The ZEISS team offers training and support to resident scientists, maximizing the impact of the technology and facilitating collaborative research opportunities.
- Innovation Suite Amenities: Located on the seventh floor, The Incubator provides a 'one-stop shop' for startups and growing businesses, offering state-of-the-art equipment, shared services, and pre-negotiated discounts on consumables.
- Engagement Opportunities: Participate in 'lunch and learn' events, talks from key opinion leaders, and on-site pop-up imaging clinics, all designed to showcase application topics and foster networking.
Featured Celldiscoverer 7 Resources
Featured Axiovert 5 Resources
Research in Action: Case Studies and Applications of Featured Imaging Technologies
Dive into real-world case studies and webinars that highlight how AI-enhanced imaging technologies are helping researchers model disease, analyze complex tissues, and bring safer, more effective drugs to market.-
Understanding and Predicting Drug-Induced Liver Damage - hepatocyte hypertrophy is a major cause of drug failure in clinical trials. Researchers like Simon Plummer are using AI-driven imaging to better model liver responses and improve drug safety.
-
AI-driven imaging is unlocking the full potential of complex in vitro models (CIVM), overcoming the limits of 2D analysis for 3D/4D data. This shift—accelerated by FDA recognition—enables scalable, automated, and biologically relevant drug discovery using advanced microscopy and analysis tools.
-
Watch a video demo of ZEISS arivis Pro using machine learning to segment organoid structures and study Wnt signaling in maturation. Once trained, the analysis runs at scale via parallel processing in ZEISS arivis Hub for high-content 3D analysis.
-
Learn how to study Wnt signaling in intestinal organoids using simple imaging and AI-powered analysis. Explore how machine learning enables segmentation of organoid layers, nuclei, and cell bodies for deeper biological insights.
-
Evaluate drug-induced cytotoxicity more efficiently with an AI-powered workflow combining widefield imaging, HCS, and automated analysis on the ZEISS Celldiscoverer 7. This approach enables precise cell segmentation, viability assessment, and faster identification of effective treatment strategies in biopharma research.
-
Traditional 2D cultures fall short in predicting drug responses, but advanced Organ-on-a-Chip models paired with high-resolution 3D imaging are changing the game.
Using the ZEISS LSM 910 with Airyscan, researchers can visualize detailed cellular behavior and gene expression, enabling earlier toxicity detection and more confident drug development.
-
Explore how 3D High Content Analysis and AI-powered imaging workflows are transforming biotech and pharma research. Learn how our solutions enable scalable, high-throughput 3D imaging with accurate segmentation and reproducible insights—accelerating discovery and reducing variability.
Meet the Team
Our dedicated ZEISS specialists are on hand to answer any questions you have about this partnership and to provide technical support for our imaging solutions in the innovations suite.Upcoming Events
Stay tuned for information on seminars, networking opportunities, training sessions, and 'lunch and learn' events - coming soon to Victoria House.